These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26406259)

  • 1. Oxytocin should not be used to augment labour: FOR: there is too much risk for too little benefit.
    Steer PJ
    BJOG; 2015 Oct; 122(11):1543. PubMed ID: 26406259
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxytocin should not be used to augment labour: AGAINST: the need for oxytocin is greatest in nulliparous women.
    Robson M
    BJOG; 2015 Oct; 122(11):1543. PubMed ID: 26406258
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of postpartum blood loss after misoprostol-induced labour.
    Majoko F
    BJOG; 2009 Oct; 116(11):1533-4; author reply 1534-5. PubMed ID: 19769754
    [No Abstract]   [Full Text] [Related]  

  • 4. Unintended clinical consequences of the implementation of a checklist-based, low-dose oxytocin protocol.
    Rohn AE; Bastek JA; Sammel MD; Wang E; Srinivas SK
    Am J Perinatol; 2015 Mar; 32(4):371-8. PubMed ID: 25217735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of labor with oxytocin increases cesarean section rate as compared with oxytocin for augmentation of spontaneous labor in nulliparous parturients controlled for lumbar epidural analgesia.
    Kaul B; Vallejo MC; Ramanathan S; Mandell G; Phelps AL; Daftary AR
    J Clin Anesth; 2004 Sep; 16(6):411-4. PubMed ID: 15567643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of postpartum blood loss after misoprostol-induced labour.
    Wuntakal R; Erskine K
    BJOG; 2009 Oct; 116(11):1535; author reply 1535-6. PubMed ID: 19769757
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxytocin at caesarean section - are we giving too much?
    Ajmal M
    BJOG; 2010 Jan; 117(1):118-9; author's reply 119. PubMed ID: 20002379
    [No Abstract]   [Full Text] [Related]  

  • 8. Recognition and response to electronic fetal heart rate patterns: impact on newborn outcomes and primary cesarean delivery rate in women undergoing induction of labor.
    Clark SL; Meyers JA; Frye DK; Garthwaite T; Lee AJ; Perlin JB
    Am J Obstet Gynecol; 2015 Apr; 212(4):494.e1-6. PubMed ID: 25460835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytotec: an effective drug for the induction of labor].
    Milchev N; Kuzmanov B; Terzhumanov R
    Akush Ginekol (Sofiia); 2003; 42(3):9-11. PubMed ID: 12858483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of malpractice claims with a focus on oxytocin use in labour.
    Jonsson M; Nordén SL; Hanson U
    Acta Obstet Gynecol Scand; 2007; 86(3):315-9. PubMed ID: 17364306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A RARE CASE OF OXYTOCIN-INDUCED MATERNAL CARDIAC BRADYARRHYTHMIA DURING LABOUR.
    Abuladze N; Gould N; Williams S; Wong A
    Georgian Med News; 2018 Dec; (285):28-31. PubMed ID: 30702065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit about labour induction, using prostaglandin, in women with a scarred uterus.
    Cogan A; Barlow P; Benali N; Murillo D; Manigart Y; Belhomme J; Rozenberg S
    Arch Gynecol Obstet; 2012 Dec; 286(6):1399-406. PubMed ID: 22836816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Judicious use of oxytocin augmentation for the management of prolonged labor.
    Rossen J; Østborg TB; Lindtjørn E; Schulz J; Eggebø TM
    Acta Obstet Gynecol Scand; 2016 Mar; 95(3):355-61. PubMed ID: 26576009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should nurses have questioned dr.'s orders? Cerny V. Williams, No. 2004-10053 (09/19/2006) -NY.
    Nurs Law Regan Rep; 2006 Oct; 47(5):4. PubMed ID: 17117603
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women.
    Hinshaw K; Simpson S; Cummings S; Hildreth A; Thornton J
    BJOG; 2008 Sep; 115(10):1289-95; discussion 1295-6. PubMed ID: 18715415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and abuse of oxytocin for augmentation of labor.
    Selin L; Almström E; Wallin G; Berg M
    Acta Obstet Gynecol Scand; 2009; 88(12):1352-7. PubMed ID: 19878049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in obstetric care related to oxytocin use. A population-based study.
    Oscarsson ME; Amer-Wåhlin I; Rydhstroem H; Källén K
    Acta Obstet Gynecol Scand; 2006; 85(9):1094-8. PubMed ID: 16929414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
    Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
    J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental steroid sulphatase deficiency: an approach to antenatal care and delivery.
    Dreyer FE; Abdulrahman GO; Waring G; Hinshaw K
    Ann Saudi Med; 2018; 38(6):445-449. PubMed ID: 30531180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin use during active labor: too much of a good thing?
    Prasad MR; Funai E
    Am J Obstet Gynecol; 2012 Dec; 207(6):439-40. PubMed ID: 23174386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.